1 | Study | 1.82% | |
2 | Health | 1.06% | |
3 | New | 0.91% | |
4 | HIV | 0.81% | |
5 | Patients | 0.76% | |
6 | Disease | 0.76% | |
7 | Cancer | 0.71% | |
8 | TB | 0.66% | |
9 | Risk | 0.61% | |
10 | May | 0.55% | |
11 | News | 0.5% | |
12 | Treatment | 0.5% | |
13 | Case | 0.45% | |
14 | Juta | 0.45% | |
15 | MedicalBrief | 0.45% | |
16 | Tuberculosis | 0.45% | |
17 | Protein | 0.4% | |
18 | Report | 0.35% | |
19 | AI | 0.35% | |
20 | Cell | 0.35% | |
21 | Kidney | 0.35% | |
22 | Review | 0.35% | |
23 | Public | 0.35% | |
24 | BMC | 0.35% | |
25 | Research | 0.35% | |
26 | Could | 0.3% | |
27 | Virus | 0.3% | |
28 | Chronic | 0.3% | |
29 | Linked | 0.3% | |
30 | Brain | 0.3% | |
31 | Africa | 0.3% | |
32 | Multiple | 0.25% | |
33 | Comprehensive | 0.25% | |
34 | Death | 0.25% | |
35 | Vietnam | 0.25% | |
36 | COVID-19 | 0.25% | |
37 | Use | 0.25% | |
38 | IBD | 0.25% | |
39 | Stroke | 0.25% | |
40 | Japan | 0.25% | |
41 | Gene | 0.25% | |
42 | Alzheimers | 0.25% | |
43 | Researchers | 0.25% | |
44 | Disorder | 0.25% | |
45 | University | 0.2% | |
46 | AllAfrica | 0.2% | |
47 | Glucose | 0.2% | |
48 | ADHD | 0.2% | |
49 | US | 0.2% | |
50 | Social | 0.2% | |
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
Next phase of TB vaccine clinical trial sparks hope of game-changing results ? top SA scientist
Bizcommunity.com
2024-03-28 15:03:41
Does First Generation Dengue Vaccine Deliver Protection ? Precision Vaccinations News
Precision Vaccinations
2024-03-28 06:54:41
Majority of Canadians view measles as dangerous, not everyone in favour of mandatory vaccine: Poll
Global News
2024-03-28 06:30:07
Adjuvanted RSVPreF3 Vaccine Could Prevent RSV Infection Among Older Adults
Pharmacy Times
2024-03-28 03:46:41
COVID vaccines cut heart failure and blood clot risks by up to 78%
The South African
2024-03-27 18:08:12
MMR vaccine slashes antibiotic use in toddlers: Nordic study shines light on broader benefits - News
Medical.Net
2024-03-27 12:55:00
Daily Maverick
2024-03-27 06:07:55
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
BioSpace
2024-03-26 19:00:17
Valneva Initiates Phase 1 Trial of Second-Generation Zika Vaccine Candidate
GlobeNewswire
2024-03-26 15:02:02